基本信息
浏览量:411
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
At the OSUCCC – James, we use the latest technologies in our search for more effective and targeted cancer treatments, and then apply our findings to patient care as quickly and responsibly as possible. As a member of the Leukemia Research Program, I have over 30 years of experience in experimental chemotherapy and drug development for patients with chronic lymphocytic leukemia (CLL) and other hematologic malignancies.
I performed the initial phase I studies on purine nucleoside analogs in patients with hematologic malignancies and conducted one of the initial phase II studies of fludarabine in patients with CLL. Together with Dr. John C. Byrd, I was among the first to investigate the potential of histone deacetylase inhibitors (depsipeptide) and cyclin-dependent kinase inhibitors (flavopiridol) in CLL, and I oversaw both laboratory and phase I clinical studies of both these agents.
My work has been published in such well-respected medical journals as Molecular Cancer Therapeutics, Blood and Journal of Clinical Oncology. I have also been honored with a number of awards, including Best Doctors in America, the Distinguished Alumnus Award from University of Pittsburgh, and more recently, The Ohio State University Distinguished Scholar Award. Additionally, I was named to the Castle Connolly list of “America's Top Doctors” from 2006 to 2019.
I performed the initial phase I studies on purine nucleoside analogs in patients with hematologic malignancies and conducted one of the initial phase II studies of fludarabine in patients with CLL. Together with Dr. John C. Byrd, I was among the first to investigate the potential of histone deacetylase inhibitors (depsipeptide) and cyclin-dependent kinase inhibitors (flavopiridol) in CLL, and I oversaw both laboratory and phase I clinical studies of both these agents.
My work has been published in such well-respected medical journals as Molecular Cancer Therapeutics, Blood and Journal of Clinical Oncology. I have also been honored with a number of awards, including Best Doctors in America, the Distinguished Alumnus Award from University of Pittsburgh, and more recently, The Ohio State University Distinguished Scholar Award. Additionally, I was named to the Castle Connolly list of “America's Top Doctors” from 2006 to 2019.
研究兴趣
论文共 7 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
L. K. Martin,G. Jia,J. Grecula, E. Harper,C. Kefauver,L. Wei,M. Knopp,I. J. Espinoza Delgado,M. Grever, T. Bekaii-Saab
European journal of cancer (2011): S449-S449
Catherine P. Leith,Kenneth J. Kopecky,I-Ming Chen,Lisette Eijdems,Marilyn L. Slovak, Thomas S. McConnell,David R. Head, James Weick,Michael R. Grever,Frederick R. Appelbaum,Cheryl L. Willman
semanticscholar(1999)
引用2浏览0引用
2
0
M. Suffness, G. G. Cragg,M. M. Grever, F. F. Grifo, G Allan Johnson,J. A. R. Mead, S. S. Schepartz,J. J. Venditti, M. Wolpert
作者统计
#Papers: 7
#Citation: 427
H-Index: 3
G-Index: 3
Sociability: 3
Diversity: 2
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn